7Q81 image
Deposition Date 2021-11-09
Release Date 2022-03-23
Last Version Date 2024-01-31
Entry Detail
PDB ID:
7Q81
Keywords:
Title:
Crystal structure of the methyltransferase-ribozyme 1, 2'-Selenomethyl-Uridine modified (with 1-methyl-adenosine)
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.85 Å
R-Value Free:
0.21
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 41 21 2
Macromolecular Entities
Polymer Type:polyribonucleotide
Molecule:RNA1
Chain IDs:A
Chain Length:14
Number of Molecules:1
Biological Source:synthetic construct
Polymer Type:polyribonucleotide
Molecule:RNA 2
Chain IDs:B
Chain Length:24
Number of Molecules:1
Biological Source:synthetic construct
Polymer Type:polyribonucleotide
Molecule:RNA 3
Chain IDs:C
Chain Length:24
Number of Molecules:1
Biological Source:synthetic construct
Primary Citation
Structure and mechanism of the methyltransferase ribozyme MTR1.
Nat.Chem.Biol. 18 547 555 (2022)
PMID: 35301481 DOI: 10.1038/s41589-022-00976-x

Abstact

RNA-catalyzed RNA methylation was recently shown to be part of the catalytic repertoire of ribozymes. The methyltransferase ribozyme MTR1 catalyzes the site-specific synthesis of 1-methyladenosine (m1A) in RNA, using O6-methylguanine (m6G) as a methyl group donor. Here, we report the crystal structure of MTR1 at a resolution of 2.8 Å, which reveals a guanine-binding site reminiscent of natural guanine riboswitches. The structure represents the postcatalytic state of a split ribozyme in complex with the m1A-containing RNA product and the demethylated cofactor guanine. The structural data suggest the mechanistic involvement of a protonated cytidine in the methyl transfer reaction. A synergistic effect of two 2'-O-methylated ribose residues in the active site results in accelerated methyl group transfer. Supported by these results, it seems plausible that modified nucleotides may have enhanced early RNA catalysis and that metabolite-binding riboswitches may resemble inactivated ribozymes that have lost their catalytic activity during evolution.

Legend

Protein

Chemical

Disease

Primary Citation of related structures